Tag: Switzerland

Roche's Evrysdi wins EU approval for spinal muscular atrophy

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) – Roche’s Evrysdi has won approval from the European Commission as the first and only at-home treatment for spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. It has

Roche, Novartis approvals in Europe signal more head-to-head competition

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) -Swiss drugmakers Roche and Novartis each won European approval for drugs on Tuesday in a sign that the rival Basel-based companies are increasingly competing for the same patients. Roche’s Evrysdi,

Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds

FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd WiegmannZURICH (Reuters) – Idorsia’s insomnia drug was accepted for review by U.S. regulators, the Swiss drugmaker said on Wednesday, as founder Jean-Paul

Switzerland virus cases top 10,000

Switzerland on Thursday joined the small group of countries to declare more than 10,000 officially-recorded cases of COVID-19, as it launched plans to start tracking crowd build-ups through mobile phone data. The health ministry said 10,661 people in the Alpine country have tested positive for the new coronavirus—nearly 1,000 more than a day earlier—while 161